Description
A-102 PERFORMANCE EVALUATION OF THE NEW POINT-OF-CARE COAGULATION ANALYZER XPRECIA STRIDE FOR MEASURING INR IN VKA-TREATED PATIENTS – COMPARISON WITH LOCAL LABORATORY AUTOMATED REFERENCE METHOD
Article: A-102 PERFORMANCE EVALUATION OF THE NEW POINT-OF-CARE COAGULATION ANALYZER XPRECIA STRIDE FOR MEASURING INR IN VKA-TREATED PATIENTS – COMPARISON WITH LOCAL LABORATORY AUTOMATED REFERENCE METHOD
€3.03
Related products
-
Article: Highlights in digestive oncology
€3.03 Add to cart -
Article: Highlights in melanoma
€3.03 Add to cart -
Article: Highlights in respiratory oncology
€3.03 Add to cart -
Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma
€3.03 Add to cart
Reviews
There are no reviews yet.